Characterization of feline cytochrome P450 2B6

References

• Achour B, Barber J, Rostami-Hodjegan A. (2011). Cytochrome P450 Pig liver pie: determination of individual cytochrome P450 isoform contents in microsomes from two pig livers using liquid chromatography in conjunction with mass spectrometry. Drug Metab Dispos 39:2130–34
   PubMed Web of Science ®Google Scholar
• Arita-Morioka K, Yamanaka K, Mizunoe Y, et al. (2015). Novel strategy for biofilm inhibition by using small molecules targeting molecular chaperone DnaK. Antimicrob Agents Chemother 59:633–41
   PubMed Web of Science ®Google Scholar
• Barnes HJ. (1996). Maximizing expression of eukaryotic cytochrome P450s in Escherichia coli. Meth Enzymol 272:3–14
   PubMed Web of Science ®Google Scholar
• Baratta MT, Zaya MJ, White JA, Locuson CW. (2009). Canine CYP2B11 metabolizes and is inhibited by anesthetic agents often co-administered in dogs. J Vet Pharmacol Ther 33:50–5
   Web of Science ®Google Scholar
• Bertone ER, Snyder LA, Moore AS. (2002). Environmental tobacco smoke and risk of malignant lymphoma in pet cats. Am J Epidemiol 156:268–73
   PubMed Web of Science ®Google Scholar
• Burke MD, Thompson S, Weaver RJ, et al. (1994). Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver microsomes. Biochem Pharmacol 48:923–36
   PubMed Web of Science ®Google Scholar
• Castell JV, Donato MT, Gómez-Lechón MJ. (2005). Metabolism and bioactivation of toxicants in the lung. The in vitro cellular approach. Exp Toxicol Pathol 57(Suppl 1):189–204
   PubMed Web of Science ®Google Scholar
• Chang TK, Crespi CL, Waxman DJ. (2006). Determination of CYP2B6 component of 7-ethoxy-4-trifluoromethylcoumarin O-deethylation activity in human liver microsomes. Methods Mol Biol 320:97–102
   PubMedGoogle Scholar
• Chang TK, Weber GF, Crespi CL, Waxman DJ. (1993). Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes. Cancer Res 53:5629–37
   PubMed Web of Science ®Google Scholar
• Chauret N, Gauthier A, Martin J, Nicoll-Griffith DA. (1997). In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse. Drug Metab Dispos 25:1130–6
   PubMed Web of Science ®Google Scholar
• Chirulli V, Longo V, Marini S, et al. (2005). CAR and PXR expression and inducibility of CYP2B and CYP3A activities in rat and rabbit lungs. Life Sci 76:2535–46
   PubMed Web of Science ®Google Scholar
• Code EL, Crespi CL, Penman BW, et al. (1997). Human cytochrome P4502B6: interindividual hepatic expression, substrate specificity, and role in procarcinogen activation. Drug Metab Dispos 25:985–93
   PubMed Web of Science ®Google Scholar
• Corcos L, Berthou F. (2008). The CYP2B subfamily. In: Ioannides C, eds. Cytochromes P450: role in the metabolism and toxicity of drugs and other xenobiotics. London: Royal Society of Chemistry, 178–99
   Google Scholar
• Court MH, Greenblatt DJ. (2000). Molecular genetic basis for deficient acetaminophen glucuronidation by cats: UGT1A6 is a pseudogene, and evidence for reduced diversity of expressed hepatic UGT1A isoforms. Pharmacogenetics 10:355–69
   PubMedGoogle Scholar
• Czerwinski M, McLemore TL, Gelboin HV, Gonzalez FJ. (1994). Quantification of CYP2B7, CYP4B1, and CYPOR messenger RNAs in normal human lung and lung tumors. Cancer Res 54:1085–91
   PubMed Web of Science ®Google Scholar
• Donato MT, Jiménez N, Castell JV, Gómez-Lechón MJ. (2004). Fluorescence-based assays for screening nine cytochrome P450 (P450) activities in intact cells expressing individual human P450 enzymes. Drug Metab Dispos 32:699–706
   PubMed Web of Science ®Google Scholar
• Denson KW. (2003). Re: environmental tobacco smoke and risk of malignant lymphoma in pet cats. Am J Epidemiol 158:1227–8
   PubMed Web of Science ®Google Scholar
• Gram TE. (1997). Chemically reactive intermediates and pulmonary xenobiotic toxicity. Pharmacol Rev 49:297–341
   PubMed Web of Science ®Google Scholar
• Hay Kraus BL, Greenblatt DJ, Venkatakrishnan K, Court MH. (2000). Evidence for propofol hydroxylation by cytochrome P4502B11 in canine liver microsomes: breed and gender differences. Xenobiotica 30:575–88
   PubMed Web of Science ®Google Scholar
• Heikkinen AT, Friedlein A, Lamerz J, et al. (2012). Mass spectrometry-based quantification of CYP enzymes to establish in vitro/in vivo scaling factors for intestinal and hepatic metabolism in beagle dog. Pharm Res 29:1832–42
   PubMed Web of Science ®Google Scholar
• Hernandez CE, Kumar S, Liu H, Halpert JR. (2006). Investigation of the role of cytochrome P450 2B4 active site residues in substrate metabolism based on crystal structures of the ligand-bound enzyme. Arch Biochem Biophys 455:61–7
   PubMed Web of Science ®Google Scholar
• Honda K, Komatsu T, Koyama F, et al. (2011). Expression of two novel cytochrome P450 3A131 and 3A132 in liver and small intestine of domestic cats. J Vet Med Sci 73:1489–92
   PubMed Web of Science ®Google Scholar
• Hosaka S, Murayama N, Satsukawa M, et al. (2015). Evaluation of 89 compounds for identification of substrates for cynomolgus monkey CYP2C76, a new bupropion/nifedipine oxidase. Drug Metab Dispos 43:27–33
   PubMed Web of Science ®Google Scholar
• Hukkanen J, Pelkonen O, Hakkola J, Raunio H. (2002). Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung. Crit Rev Toxicol 32:391–411
   PubMed Web of Science ®Google Scholar
• Iwata H, Fujita K, Kushida H, et al. (1998). High catalytic activity of human cytochrome P450 co-expressed with human NADPH-cytochrome P450 reductase in Escherichia coli. Biochem Pharmacol 55:1315–25
   PubMed Web of Science ®Google Scholar
• Komatsu T, Honda K, Kubota A, et al. (2010). Molecular cloning and expression of cytochrome P450 2D6 in the livers of domestic cats. J Vet Med Sci 72:1633–6
   PubMed Web of Science ®Google Scholar
• Lamba V, Lamba J, Yasuda K, et al. (2003). Hepatic CYP2B6 expression: gender andethnicdifferencesand relationshipto CYP2B6 genotype and CAR (constitutive androstanereceptor) expression. J Pharmacol Exp Ther 307:906–22
   PubMed Web of Science ®Google Scholar
• Lindberg RL, Negishi M. (1989). Alteration of mouse cytochrome P450coh substrate specificity by mutation of a single amino-acid residue. Nature 339:632–4
   PubMed Web of Science ®Google Scholar
• Malenke JR, Magnanou E, Thomas K, Dearing MD. (2012). Cytochrome P450 2B diversity and dietary novelty in the herbivorous, desert woodrat (Neotoma lepida). PLoS One 7:e41510
   Google Scholar
• Mayumi K, Hanioka N, Masuda K, et al. (2013). Characterization of marmoset CYP2B6: cDNA cloning, protein expression and enzymatic functions. Biochem Pharmacol 85:1182–94
   PubMed Web of Science ®Google Scholar
• McLaughlin LA, Dickmann LJ, Wolf CR, Henderson CJ. (2008). Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening. Drug Metab Dispos 36:1322–31
   PubMed Web of Science ®Google Scholar
• Nelson DR. (2009). The Cytochrome P450 Homepage. Human Genomics 4:59–65
   PubMedGoogle Scholar
• Nishimura M, Yaguti H, Yoshitsugu H, et al. (2003). Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR. Yakugaku Zasshi 123:369–75
   PubMed Web of Science ®Google Scholar
• Okamatsu G, Komatsu T, Kubota A, et al. (2015). Identification and functional characterization of novel feline cytochrome P450 2A. Xenobiotica 45:503–10
   PubMed Web of Science ®Google Scholar
• Pearce R, Greenway D, Parkinson A. (1992). Species differences and interindividual variation in liver microsomal cytochrome P450 2A enzymes: effects on coumarin, dicumarol, and testosterone oxidation. Arch Biochem Biophys 298:211–25
   PubMed Web of Science ®Google Scholar
• Pritchard MP, McLaughlin L, Friedberg T. (2006). Establishment of functional human cytochrome P450 monooxygenase systems in Escherichia coli. In: Phillips IR, Elizabeth AS, eds. Methods in molecular biology. New Jersey: Human Press, 19–29
   Google Scholar
• Rendic S. (2002). Summary of information on human CYP enzymes: Human P450 metabolism data. Drug Metab Rev 34:83–448
   PubMed Web of Science ®Google Scholar
• Shah SS, Sanda S, Regmi NL, et al. (2007). Characterization of cytochrome P450-mediated drug metabolism in cats. J Vet Pharmacol Ther 30:422–8
   PubMed Web of Science ®Google Scholar
• Shimada T, Yun C-H, Yamazaki H, et al. (1992). Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens. Mol Pharmacol 41:856–64
   PubMed Web of Science ®Google Scholar
• Smith GB, Bend JR, Bedard LL, et al. (2003). Biotransformation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in peripheral human lung microsomes. Drug Metab Dispos 31:1134–41
   PubMed Web of Science ®Google Scholar
• Uehara S, Murayama N, Nakanishi Y, et al. (2011). Immunochemical detection of cytochrome P450 enzymes in liver microsomes of 27 cynomolgus monkeys. J Pharmacol Exp Ther 339:654–61
   PubMed Web of Science ®Google Scholar
• Uno Y, Matsuno K, Nakamura C, et al. (2009). Identification and characterization of CYP2B6 cDNA in cynomolgus macaques (Macaca fascicularis). J Vet Med Sci 71:1653–6
   PubMed Web of Science ®Google Scholar
• van Beusekom CD, Schipper L, Fink-Gremmels J. (2010). Cytochrome P450-mediated hepatic metabolism of new fluorescent substrates in cats and dogs. J Vet Pharmacol Ther 33:519–27
   PubMed Web of Science ®Google Scholar
• Wang H, Tompkins LM. (2008). CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme. Curr Drug Metab 9:598–610
   PubMed Web of Science ®Google Scholar
• Walsky RL, Astuccio AV, Obach RS. (2006). Evaluation of 227 drugs for in vitro inhibition of cytochrome P450 2B6. J Clin Pharmacol 46:1426–38
   PubMed Web of Science ®Google Scholar